ENGOLCE

Serial Number 98257831
731

Registration Progress

Application Filed
Nov 7, 2023
Under Examination
Jun 18, 2024
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Dec 18, 2025 139 days

Trademark Image

ENGOLCE

Basic Information

Serial Number
98257831
Filing Date
November 7, 2023
Published for Opposition
April 23, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
May 19, 2025
Application
Pending
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
3-2-10, Dosho-machi,
Chuo-ku, Osaka-shi Osa JAPAN541-
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
Chuo-ku, Osaka-shi Osa JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
Chuo-ku, Osaka-shi Osa JP

Legal Representation

Attorney
A. Tally Eitan

USPTO Deadlines

Next Deadline
139 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 18, 2025
Extension Available
Until June 18, 2025

Application History

27 events
Date Code Type Description Documents
May 19, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 19, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 19, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
May 19, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 14, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 13, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 19, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 18, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 14, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 8, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 5, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of parkinsons disease

Additional Information

Design Mark
The mark consists of the stylized wording "ENGOLCE" with two fading concentric incomplete circles to the left of and wrapping around the letter "E", with the outer circle being a semicircle and the inner circle being more than a semicircle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005